Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Dec 5, 2017

29745_dirs_2017-12-05_1b06e957-1709-4f5c-a856-26d8057a86d8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-12-03

Reporting Person: Fry Stephen F (SVP, HR & Diversity)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-03 Common Stock M 7557 Acquired 86501 Direct
2017-12-03 Common Stock F 3567 $85.32 Disposed 82934 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-03 Restricted Stock Unit $ M 7557 Disposed 2017-12-03 Common Stock (7557.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 168 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.